Table 2 Categorized glucocorticoid level of exposure variables among exposed patients during the study period.

From: Risk of fracture according to glucocorticoid use after renal biopsy: a nationwide population-based study

Systemic GC exposure

Exposed (n = 5,471)

P-value

Daily dose (mg/day)

 

< 0.0001

≤ 5

344 (6)

 

5 to ≤ 10

1,366 (25)

 

10 to ≤ 20

1676 (31)

 

> 20

2085 (38)

 

Cumulative dose (mg)

 

< 0.0001

≤ 450

2044 (37)

 

450 to ≤ 900

239 (4)

 

900 to ≤ 1825

222 (4)

 

1825 to ≤ 3,600

536 (10)

 

> 3,600

2,430 (45)

 

Peak dose (mg/day)

 

< 0.0001

≤ 10

896 (16)

 

10 to ≤ 30

1,400 (26)

 

30 to ≤ 60

1,133 (21)

 

> 60

2042 (37)

 

Cumulative days

 

< 0.0001

≤ 120

2,958 (54)

 

120 to ≤ 180

424 (8)

 

180 to ≤ 365

897 (16)

 

> 365

1,192 (22)

 
  1. Values are presented as n (%). All glucocorticoid exposure variables were calculated with the equivalent dose (mg) according to the relative potency. The P-value calculated from the Chi-square test for goodness-of-fit is shown.
  2. GC glucocorticoid.
Back to article page